Vera Therapeutics, Inc.(VERA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

VERA Vera Therapeutics, Inc.

Trading 09-25 11:35:16 EDT

32.72

-0.62

-1.86%

High33.44	Low32.50	Vol280.26K
Open33.44	D1 Closing33.34	Amplitude2.82%
Mkt Cap2.35B	Tradable Cap1.71B	Total Shares71.71M
T/O9.20M	T/O Rate0.53%	Tradable Shares52.39M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"VERA","market":"US","secType":"STK","nameCN":"Vera Therapeutics, Inc.","latestPrice":32.72,"timestamp":1790350511972,"preClose":33.34,"halted":0,"volume":280256,"delay":0,"changeRate":-0.018596280743851366,"floatShares":52394100,"shares":71713905,"eps":-5.898389,"marketStatus":"Trading","change":-0.62,"latestTime":"09-25 11:35:16 EDT","open":33.44,"high":33.44,"low":32.5,"amount":9201510.72512,"amplitude":0.028194,"askPrice":32.8,"askSize":2,"bidPrice":32.65,"bidSize":210,"shortable":3,"etf":0,"ttmEps":-5.898389,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1790366400000},"marketStatusCode":2,"adr":0,"listingDate":1620964800000,"exchange":"NASDAQ","adjPreClose":33.34,"preHourTrading":{"tag":"盘前","latestPrice":33.87,"preClose":33.34,"latestTime":"09:26 EDT","volume":2649,"amount":88925.322057,"timestamp":1790342801735,"change":0.53,"changeRate":0.015897,"amplitude":0.038092},"postHourTrading":{"tag":"盘后","latestPrice":33.34,"preClose":33.34,"latestTime":"19:49 EDT","volume":68704,"amount":2290555.8687,"timestamp":1790293771500,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.390276,"impliedVol":0.6513,"impliedVolPercentile":0.0996},"requestUrl":"/m/hq/s/VERA","defaultTab":"news","newsList":[{"id":"2669336433","title":"Vera Therapeutics Down over 8%, on Track for Largest Percent Decrease Since November 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2669336433","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669336433?lang=en_us&edition=fundamental","pubTime":"2026-09-24 01:58","pubTimestamp":1790186280,"startTime":"0","endTime":"0","summary":"Vera Therapeutics, Inc. Class A  is currently at $33.22, down $3.04 or 8.4%--On pace for largest percent decrease since Nov. 13, 2025, when it fell 8.72%--Snaps a two day winning streak--Down 2.54% month-to-date; on pace for worst month since July 2026, when it fell 25.19%--Down 34.41% year-to-date--Down 40.34% from its all-time closing high of $55.67 on Dec. 24, 2025--Up 27.07% from 52 weeks ago , when it closed at $26.14--Down 40.34% from its 52-week closing high of $55.67 on Dec. 24, 2025--Up 37.82% from its 52-week closing low of $24.10 on Nov. 5, 2025--Traded as low as $32.63--Down 10.01% at today's intraday low; largest intraday percent decrease since July 2, 2026, when it fell as much as 13.83%All data as of 1:55:47 PM ETSource: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4539","BK4585","VERA","LU2324357040.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668682992","title":"Vera Therapeutics CEO Fordyce Marshall Disposes of USD 684,500 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2668682992","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668682992?lang=en_us&edition=fundamental","pubTime":"2026-09-18 04:29","pubTimestamp":1789676963,"startTime":"0","endTime":"0","summary":"Vera Therapeutics CEO Fordyce Marshall disposes of USD 684,500 in common sharesVera Therapeutics President and CEO Marshall Fordyce exercised stock options for 18,500 Class A shares at $2.9.He sold 18","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nNDL2GKlmB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Vera Therapeutics CEO Fordyce Marshall Disposes of USD 684,500 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VERA","LU2324357040.USD","BK4585","BK4139","BK4588","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667600940","title":"Analysts Offer Insights on Healthcare Companies: Viatris (VTRS) and Vera Therapeutics (VERA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667600940","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667600940?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:10","pubTimestamp":1789557055,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Viatris (VTRS) and Vera Therapeutics (VERA). Viatr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-viatris-vtrs-and-vera-therapeutics-vera-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-viatris-vtrs-and-vera-therapeutics-vera-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2087621335.USD","BK4583","BK4539","BK4007","LU0128526141.USD","LU0029874061.USD","BK4585","HCSG","XBI","BK4139","BK4137","VTRS","XLV","BK4588","LU2324357040.USD","LABU","BK4581","VERA","LU1839511570.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667862671","title":"U.S. Stocks on the MOVE-Forgent Power, Vera Bradley, Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2667862671","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667862671?lang=en_us&edition=fundamental","pubTime":"2026-09-16 00:53","pubTimestamp":1789491227,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Forgent Power, Vera Bradley, Wells FargoSeptember 15 (Reuters)-Wall Street's main indexes slipped on Tuesday, dragged down by higher crude prices, elevated Treasury yields","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL6N457105:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09311","KBWB","CRPT","09711","BITQ","AXON","RIOT","BIVI","OWNB","HRTS","MEMS","CNTB","IYF","LLY","WGMI","WFC","PDM","HUT","CANC","SYY","VERA","MRAL","RIVN","07711","RVNL","WAY","LLYZ","RXL","TRUH","COIN","DAPP","ICOI","IMRA","MARA","THNR","LFGY","XLV","PEJ","COIO","FPS","OTIS","IHE","VRA","LEGN","LLII","PJP","PLAY","GDOC","COII","CONL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667496625","title":"Top Midday Stories: Waystar Reportedly Mulling Potential Sale; Intel-Backed Altera Says Parent Company Files Confidentially for IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2667496625","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667496625?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:42","pubTimestamp":1789486941,"startTime":"0","endTime":"0","summary":"All three major US stock indexes were down in late-morning trading Tuesday, as Treasury yields continued to rise and investors increasingly expected the Federal Reserve to raise its benchmark interest","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BFSS8Q28.SGD","AIFD","IE00BKVL7J92.USD","LU2065169927.USD","LU0109391861.USD","SG9999014898.SGD","LU2047632596.USD","BK4571","LU1914381329.SGD","LU0823417653.USD","LU2168564495.EUR","IE00B775H168.HKD","LU1496350502.SGD","LU2360032135.SGD","LU0353189763.USD","LU0354030511.USD","INYY","MIC","LU1244550494.USD","MULL","WLDR","LU1035775433.USD","LU0251132253.USD","LU0053666078.USD","IE000Q6AESB8.SGD","LU0274383776.USD","LU2506952097.USD","LU2552382132.HKD","SINTCmain","LU1116320737.USD","BK4127","LU1046421795.USD","XNTK","LU0203202063.USD","LU0289739343.SGD","LU0889566641.SGD","LU1720051017.SGD","LU2462591277.SGD","LU2125154935.USD","IE00BKDWB100.SGD","LU0823417737.USD","LU1066051811.HKD","LU1974910355.USD","LU0795875086.SGD","LU2360107325.USD","SHOC","IE00B4JS1V06.HKD","LU1935042488.USD","LU2097344431.USD","LU0143551892.USD","IE00B19Z3B42.SGD","LU2505996681.GBP","LU0719512351.SGD","VT","LU1496350171.SGD","LU0323591593.USD","LU0048584097.USD","LU1778281490.HKD","LU0154236417.USD","LU1400636657.SGD","IE00BK4W5L77.USD","LU2028103732.USD","LU1551013425.SGD","LU2290526834.HKD","IE00BQXX3F31.USD","IE00BK4W5M84.HKD","AAPX","LU2264538146.SGD","LU2361044865.SGD","LU0456855351.SGD","LU0965509283.SGD","LU2430703178.SGD","LU0096364046.USD","SMU00main","LU1506573853.SGD","LU0472753341.HKD","LU1934455277.USD","LU0648000940.SGD","LU1989772840.SGD","LU1670756490.USD","LU1642822529.SGD","SG9999014906.USD","LU0308772762.SGD","CHPS","IE000F7OJYX1.SGD","METV","MACW.SI","LU1242518931.SGD","LU2750360997.AUD","BK4501","LU2077746001.SGD","IE0034235303.USD","BK4596","HK0000306685.HKD","INT","LU1935043023.USD","LU2236285917.USD","LU0072462426.USD","LU0321505868.SGD","LU0158827948.USD","LU0210528500.USD","LU0238689110.USD","ROM","LU0096362180.USD","LU2505996509.AUD","IOSX","BK4516","LU1823568750.SGD","ABFL","LU1202635105.USD","BK4170","IPO","LU0942090050.USD","SG9999015986.USD","LU1582987597.SGD","IE00BLSP4239.USD","LU0158827781.USD","BK4561","BK4527","HK0000320223.HKD","BK4576","LU0784385840.USD","LU0784385170.HKD","LU0553294199.USD","AAPB","LU2931357623.SGD","LU2125154778.USD","IE00BDCRKT87.USD","LU2237443382.USD","LU2462591350.SGD","LU0784383803.USD","LU0985320562.USD","LU2471134879.HKD","IE000M9KFDE8.USD","SG9999017495.SGD","LU1935043452.HKD","LU0070302665.USD","LU2092627202.USD","LU0823434583.USD","LU0823421416.USD","LU2089283258.USD","BK4553","SAAPLmain","LU0211327993.USD","LU2347655073.USD","LU0203345920.USD","IE00BN8TJ469.HKD","LU0708994859.HKD","LU2065171311.SGD","LU2471134952.CNY","LU2506951958.HKD","LU2750360641.GBP","LU1791710582.SGD","LU0820561818.USD","SG9999018865.SGD","LU0267386448.USD","TTXU","LU1066053197.SGD","LU0048573561.USD","LU0079474960.USD","LU2746668461.USD","LU2756315318.SGD","LU2087625088.SGD","CHAT","HK0000819398.USD","BK4139","LU2087621335.USD","LU2462157665.USD","MUZ","LU1934455863.HKD","LU2063271972.USD","USXF","SOXQ","BK4141","BK4581","LU1791710400.SGD","LU2242649171.HKD","IE00B19Z9505.USD","LU0494093205.USD","LU1323610961.USD","LU0011850046.USD","LU1145028129.USD","BK4529","IE0009G5SDU7.USD","LU0097036916.USD","LU1037948541.HKD","LU2552382058.USD","LU2023250504.SGD","IE00BMPRXR70.SGD","LU0788109477.HKD","LU1852331112.SGD","SGXZ80539844.SGD","LEGR","LINT","LU0689472784.USD","LU2054465674.USD","LU0949170772.SGD","LU0162691827.USD","IE00B3S45H60.SGD","LU0444973449.USD","LU1064131342.USD","LU2430703251.USD","IE00BJJMRY28.SGD","RULE","LU2543165471.USD","LU1232071149.USD","LU1571399168.USD","IE000ITXATA3.USD","IE00BJTD4V19.USD","ARTY","LU0889565833.HKD","LU2756315664.SGD","BK4605","LU1868836914.USD","IE000W1ABFV2.USD","LU1804176565.USD","LU2360106780.USD","IE0009356076.USD","LU2458330169.SGD","AIS","LU2381873111.SGD","LU1720051108.HKD","IE00BQXX3D17.EUR","LU3102509885.SGD","LU0882574139.USD","LU2361044949.HKD","LU2102340556.USD","LU2458330243.SGD","LU1206712785.SGD","SGXZ99366536.SGD","BAI","LU0980610538.SGD","IXN","LU2106854487.HKD","LU0965508806.USD","BK4579","LU2860962120.EUR","IE00BJJMRX11.SGD","LU1815336091.USD","LU0069063385.USD","LU0124676726.USD","LU0320765059.SGD","LU2065170008.USD","IE0004445015.USD","AIQ","LU0444971666.USD","FTXL","MUU","BK4543","LU2764262908.HKD","LU1868836757.USD","SGXZ81514606.USD","LU0861579265.USD","LU0289961442.SGD","LU0466842654.USD","IE0000B7K699.USD","LU0081259029.USD","LU0157215616.USD","HK0000914686.HKD","LU2133065610.SGD","LU1037948897.HKD","LU2213496289.HKD","SG9999002232.USD","LU1582987324.SGD","LU1935042215.USD","SGXZ51526630.SGD","LU0251142724.SGD","SG9999002224.SGD","LU0061475181.USD","FDTX","LU1144417596.USD","LU2237443465.HKD","LU0130103400.USD","LU1366333091.USD","LU0215105999.USD","EVR","LU0133085943.USD","LU2108987350.USD","LU0557290698.USD","SG9999015945.SGD","TTEQ","BK4555","BK4512","SG9999014914.USD","EFIV","LU0127658192.USD","LU0683600562.USD","SG9999015952.SGD","LU2552382215.SGD","IE00BJTD4N35.SGD","DRIV","IE0001KFT4U8.USD","LU1066051498.USD","LU0545039389.USD","SG9999015341.SGD","LU0316494557.USD","IE00BN29S564.USD","LU2211815571.USD","LU1935043536.SGD","LU0726765562.USD","LU2506952170.USD","APLY","FAI","IE000YTNTUN2.SGD","LU0528227936.USD","SG9999014567.USD","AAPW","LU1989764664.SGD","LU1935042991.SGD","LU0130518102.USD","LU1400636574.HKD","LU0792757196.USD","BK4507","BK4585","LU0738911758.USD","SG9999000418.SGD","LU1366192091.USD","LU1235294995.USD","AAPE","LU2286300806.USD","SG9999014559.SGD","SG9999015358.SGD","SGXZ31699556.SGD","BK4099","LU2083900584.USD","LU1119994496.HKD","FXL","LU2637965513.SGD","IE00BJLML261.HKD","LU0757428866.USD","IE00B775SV38.USD","LU2602419157.SGD","LU0912757837.SGD","LU1291159041.SGD","LU2111349929.HKD","SOXX","BK4612","LU0964807845.USD","LU0417517546.SGD","LU0648001328.SGD","LU2100268510.USD","LU0689626769.HKD","LU0310800379.SGD","IE00BQXX3C00.GBP","LU0345770308.USD","LU2089985449.USD","AAPL","LU0056508442.USD","LU0130517989.USD","LU0823421333.USD","LU2403377893.USD","IE000BZT7R73.USD","LU1803068979.SGD","BK4533","LU0072461881.USD","XLK","LU0211331839.USD","IE00B4YYXB79.USD","SG9999014542.SGD","LU0210533765.USD","LU0130102774.USD","BK4554","IE00B5949003.HKD","LU1645745479.HKD","LU0949170426.SGD","LU2954938101.SGD","IE000MB6IJN5.SGD","LU2357627491.SGD","LU2097344357.USD","LU0234570918.USD","LU2452424414.USD","LU2361045086.USD","IE0005OL40V9.USD","LU1839511570.USD","IE00BMPRXQ63.HKD","IE00B19Z8X17.USD","LU0265550359.USD","LU2324357040.USD","LU2461242641.AUD","LU2463028550.USD","INTW","LU0057025933.USD","IE0004091025.USD","IE000SO60NU8.SGD","LU0077335932.USD","PTF","LU1074936037.SGD","MUG","HK0000532082.HKD","LU1169590202.USD","MUD","LU0310799852.SGD","LU1629891620.HKD","LU2244417387.USD","LU0795875169.SGD","LU0320765489.SGD","LU0321505439.SGD","BK4539","HK0000304797.USD","EMSF","LU0868494708.USD","LU2237443622.USD","IE00B19Z3581.USD","BK4505","LU0820562030.AUD","PSI","LU0345768153.USD","INTC","LU1861220033.SGD","LU1988902786.USD","LU0314106906.USD","LU0109392836.USD","LU2168564222.USD","LU1582986359.USD","LU0082616367.USD","LU0174119429.USD","BK4575","LU0354030438.USD","LU0203347892.USD","LU1267930813.SGD","SG9999015978.USD","LU0979878070.USD","LU1989771016.USD","SG9999014575.USD","LU2247934214.USD","LU0820561909.HKD","TYLG","LU1267930730.SGD","LU2347655156.SGD","CGGO","LU0314104364.USD","LU0345768740.USD","LU0170899867.USD","LU1718418525.SGD","LU2168564149.EUR","LU0198837287.USD","LU2360107168.USD","QQQA","IE0034235295.USD","IE00B19Z8W00.USD","LU0210536198.USD","AAPY","LU1201861165.SGD","IE00BWXC8680.SGD","LU1582986433.USD","LU2089284900.SGD","BK4574","SPTE","LU0859254822.USD","LU2357305700.SGD","ANT","LU1989764748.USD","LU1244550221.USD","CMAG","LU2191332357.HKD","IE00BLSP4452.SGD","LU0256863902.USD","LU0070217475.USD","WUGI","HK0000914660.USD","LU0640476718.USD","LU1814569148.SGD","LU2168563687.JPY","LU2271345857.HKD","LU2023251221.USD","LU2242650005.HKD","LU0353189680.USD","LU0823434740.USD","LU1206713676.USD","LU2065171402.SGD","LU0029864427.USD","LU1066051225.USD","LU0477156953.USD","LU0187121727.USD","IE00B3SWFQ91.USD","HK0000320264.USD","BK4167","LU0724617625.USD","IE00BFSS7M15.SGD","LU0950375773.USD","LU1868836591.USD","LU2168564065.EUR","LU1979441026.SGD","LU1674673691.USD","LU1917777945.USD","IE0003U64NQ7.SGD","LU1815336760.USD","BK4532","LU2023250843.SGD","LU1201861249.SGD","SMH","LU0256863811.USD","LU2506951875.HKD","SG9999018857.SGD","LU1548497426.USD","LU1400636491.USD","LU2592432038.USD","LU0006061336.USD","DISK","LU1301847155.USD","LU2430703095.HKD","VGT","CHPX","LU1861219969.SGD","LU2896262040.SGD","DRMY","LU2764263203.CNY","SG9999001424.SGD","IE0002270589.USD","LU2746668974.SGD","LU2023250330.USD","FTEC","LU0476273544.USD","LU0203201768.USD","LU1732799900.SGD","LU2764263039.SGD","LU2456880835.USD","LU0345769631.USD","BK4573","LU1084165304.USD","LU1868837136.USD","LU2720916845.USD","LU1551013342.USD","LU0128525929.USD","IE00BZ1G4Q59.USD","LU0265550946.USD","LU0787776722.HKD","IE0004445239.USD","IE00BDRTCR15.USD","LU2237443978.SGD","LU1815333072.USD","HK0000306701.USD","LU2999663052.SGD","LU1732800096.USD","BK4592","LU0061474960.USD","LU1116320901.HKD","VERA","LU0251131958.USD","BK4598","LU1169589451.USD","LU0642271901.SGD","LU1069344957.HKD","LU0080751232.USD","LU1242518857.USD","LU0943347566.SGD","LU1861214812.USD","WAY","BK4566","BK4550","LU2420271590.USD","LU1861215975.USD","LU1316542783.SGD","LU0957791311.USD","LU2237438978.USD","LU0511384066.AUD","LU1934455194.USD","BK4534","BK4588","LU0149725797.USD","LU1127390331.HKD","LU0477156797.USD","MUYY","LU2148611432.USD","IE000KEQY171.SGD","LU0957808578.USD","MU","LU0345770993.USD","IETC","LU0211328371.USD","IE00B7KXQ091.USD","LU0672654240.SGD","AAPU","LU0965509101.SGD","LU0786609619.USD","LU0661504455.SGD","IE00B1BXHZ80.USD","LU1280957306.USD","BK4559","LU2250418816.HKD","LU0345769128.USD","LU1267930573.SGD","JGRO","TRFK","GM","04335","IE000WAW04H5.SGD","BK4602","LU0868494617.USD","BOBP","LU0234572021.USD","LU1261432733.SGD","LU1699723380.USD","LU2048586759.USD","LU0965509010.AUD","LU1003077747.HKD","LU2237443549.SGD","EGGY","LU2471134523.USD","LU0784384876.USD","LU1989772923.USD","IE00BMPRXN33.USD","IE00BSNM7G36.USD","SG9999014880.SGD","LU2092937148.SGD","BK4515","LU2471134796.USD","LU2417539215.USD","IE00B7SZLL34.SGD","LU0208291251.USD","IE00B1XK9C88.USD","IE0004086264.USD","LU1244550577.SGD","HK0000304805.HKD","GB00BDT5M118.USD","LU2237443895.HKD","LU0742534661.SGD","IE00BYXW3230.USD","LU1267930490.SGD","LU2265009873.SGD","LU2487616109.SGD","LU0708995401.HKD","AAPD","LU1868837300.USD","LU0348723411.USD","IE00BBT3K403.USD","HBMX","BK4535","LU1674673428.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667625436","title":"Rami Katkhuda Reiterates Buy on Trutakna, Citing Strong Clinical and Early Commercial Traction; $90 Price Target Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=2667625436","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667625436?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:25","pubTimestamp":1789485925,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Rami Katkhuda has maintained their bullish stance on VERA stock, giving a Buy rating today. Rami Katkhuda has given his Buy...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/rami-katkhuda-reiterates-buy-on-trutakna-citing-strong-clinical-and-early-commercial-traction-90-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/rami-katkhuda-reiterates-buy-on-trutakna-citing-strong-clinical-and-early-commercial-traction-90-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4588","VERA","LU2324357040.USD","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667628410","title":"Vera Therapeutics ORIGIN 3 study results positive, says Raymond James","url":"https://stock-news.laohu8.com/highlight/detail?id=2667628410","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667628410?lang=en_us&edition=fundamental","pubTime":"2026-09-15 22:10","pubTimestamp":1789481414,"startTime":"0","endTime":"0","summary":"After Vera Therapeutics (VERA) reported the final efficacy analysis for their pivotal ORIGIN 3 study needed for full approval of Trutakna in IgAN, ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vera-therapeutics-origin-3-study-results-positive-says-raymond-james-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vera-therapeutics-origin-3-study-results-positive-says-raymond-james-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1363072403.SGD","BK4585","LU0971096721.USD","LU2265009873.SGD","BK4139","BK4588","VERA","IE00B64PRP62.GBP","LU1804176565.USD","RJF","LU2324357040.USD","IE00BGHQF748.EUR","BK4127","BK4539","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667640245","title":"Vera Therapeutics Shares up 1.5% After Kidney Disease Drug Meets Goals in Confirmatory Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2667640245","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667640245?lang=en_us&edition=fundamental","pubTime":"2026-09-15 21:40","pubTimestamp":1789479632,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL1N4570GY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","LU2324357040.USD","VERA","BK4585","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667642866","title":"U.S. Stocks on the MOVE-Eli Lilly, Waystar, Sysco","url":"https://stock-news.laohu8.com/highlight/detail?id=2667642866","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667642866?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:09","pubTimestamp":1789474187,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Eli Lilly, Waystar, SyscoSeptember 15 (Reuters)-U.S. stock index futures slipped on Tuesday as higher crude prices, elevated Treasury yields and an uncertain outlook for A","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL6N4570PZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0097036916.USD","DAPP","IBLC","LU0648000940.SGD","TRUH","CONY","BLCK","IE0005OL40V9.USD","SG9999001176.SGD","AGNG","LU1868836914.USD","LU0820561818.USD","LU2168564222.USD","HUT","IE0004445015.USD","LU0109391861.USD","WDNA","BK4581","IE00B1BXHZ80.USD","IE0002141913.USD","BK4539","LU2106854487.HKD","BK4596","MHX","09311","GDOC","LU0823434583.USD","TLX","IYH","COYY","BK4554","LU1691799644.USD","LU0234572021.USD","LU2468319806.SGD","COIA","07711","LU1989771016.USD","LU2063271972.USD","SG9999018857.SGD","LU2236285917.USD","IE00B1XK9C88.USD","MARA","LU0353189680.USD","RIOT","LU0210536198.USD","LU0471298694.HKD","LU2237443549.SGD","LU0094547139.USD","LU0323591593.USD","BK4535","LU0787776722.HKD","PJP","LU2237443622.USD","SG9999015952.SGD","LU1894683348.USD","COIN","LU1201861165.SGD","RIVC","BK4600","MHIP","LU2089984988.USD","MEDX","BK4102","BK4516","HUTG","SG9999018865.SGD","RIOX","IE00BK4W5L77.USD","BK4216","LU0174119429.USD","SG9999014898.SGD","LU0096364046.USD","LU1989763427.SGD","LU2471134879.HKD","JDOC","LLYZ","BKCH","LU0266013472.USD","LU2264538146.SGD","LU2471134796.USD","LU2491050071.SGD","IDRV","MNRS","LU1064131342.USD","LU1989763690.USD","IE00BK4W5M84.HKD","LU0997586861.USD","LU2211817866.USD","RVNL","SGXZ57979304.SGD","LU2237438978.USD","FHLC","IE00B775H168.HKD","LU1366192091.USD","PLAY","LU2462157665.USD","LU0203202063.USD","LU2456880835.USD","LU0122379950.USD","LU1280957306.USD","PEJ","BK4167","BK4551","LU1894683264.USD","LU1093756168.USD","LU1868837136.USD","LU2237443465.HKD","SGXZ51526630.SGD","IE00BJJMRY28.SGD","LU2237443382.USD","09711","BK4599","LU2211815571.USD","LU1720051017.SGD","BITQ","LU2552382215.SGD","BK4139","LU1720051108.HKD","LU2896262040.SGD","LU1988902786.USD","LU2361045086.USD","LU2462591350.SGD","LU1868836757.USD","RIVN","LU2750360997.AUD","CONI","LU1023059063.AUD","IMRA","CURE","LU2168564065.EUR","LU0354030511.USD","LU2087625088.SGD","LU2552382132.HKD","IE00BN29S564.USD","TRMD","LU1629891620.HKD","LU2552382058.USD","BK4534","FDIG","LU0820561909.HKD","LU1551013342.USD","MARO","LU1712237335.SGD","LU2168563687.JPY","LU1548497426.USD","FDRV","LU1169590202.USD","LU2111349929.HKD","COIW","LU0106261372.USD","LU1804176565.USD","LU0708995401.HKD","LU2089284900.SGD","LU0158827781.USD","BK4007","IE00BJJMRZ35.SGD","LU1623119135.USD","OZEM","FIAT","LLY","LU0320765059.SGD","CANC","LLYX","MRAL","IE00B2B36J28.USD","LU1145028129.USD","LU1861559042.SGD","BK4144","LU0683600562.USD","CONX","LU0109394709.USD","LU1814569148.SGD","LU0289739699.SGD","LU0640476718.USD","LU2089283258.USD","LU0417517546.SGD","TMED","SG9999013999.USD","LU2360106947.USD","LU2417539215.USD","IE00BKPKM429.USD","COIO","LU1127390331.HKD","LU0823416689.USD","LU0345770993.USD","BK4555","LU2028103732.USD","MAAY","LU1868837300.USD","LU1169589451.USD","LU0823434740.USD","IE00BFSS8Q28.SGD","LU0345770308.USD","LU1979441026.SGD","BK4585","LU1035775433.USD","LU1861220207.SGD","LU1974910355.USD","HRTS","RXL","BK4099","LU0757428866.USD","LU2108987350.USD","LU1232071149.USD","LU2357305700.SGD","SG9999014914.USD","SG9999001176.USD","IE00BFTCPJ56.SGD","LU2023251221.USD","SG9999015978.USD","SG9999015945.SGD","IE00B3T34201.USD","BK4547","LU0079474960.USD","CRPT","LU0477156797.USD","LLII","LU1267930730.SGD","COII","LU2360107671.USD","LU2237443978.SGD","LU0198837287.USD","LU2491049909.HKD","IE00BJT1NW94.SGD","LU2756315664.SGD","LU1291159041.SGD","COIX","GCPU","BLOX","LU0964807845.USD","PPH","MEDI","IE00BFSS7M15.SGD","LU0466842654.USD","LU0225283273.USD","LU0820562030.AUD","GB00BDT5M118.USD","XLV","LU0006306889.USD","LU2112291526.USD","IHE","LU1061106388.HKD","LU0385154629.USD","WAY","VHT","BK4023","OWNB","COIG","LU1868836591.USD","BK4209","LU1861217088.USD","LU0471298777.SGD","LU1057294990.SGD","LU2471134952.CNY","BK4595","LFGY","LU0689472784.USD","LU0786609619.USD","LU0130518102.USD","SYY","ICOI","LU0456855351.SGD","LU0320765992.SGD","IE00B4JS1V06.HKD","LU0432979614.USD","LU2361044949.HKD","LU2213496289.HKD","CONL","BK4533","SG9999017495.SGD","LU2461242641.AUD","BK4504","LU2471134523.USD","LU1551013425.SGD","LU2750360641.GBP","FINX","RTYY","BK4112","IE0004445239.USD","SGXZ81514606.USD","LU2168564149.EUR","BK4588","SG9999014880.SGD","LU0058720904.USD","SG9999014906.USD","LU0353189763.USD","LU0238689110.USD","LU2324357040.USD","LU0256863902.USD","LU0672654240.SGD","LU1323610961.USD","LU0203201768.USD","LU0882574055.USD","IE00BJJMRX11.SGD","VERA","LU1069344957.HKD","IE00BJLML261.HKD","LU1917777945.USD","IE00B7KXQ091.USD","LU2756315318.SGD","SGXZ99366536.SGD","07311","LU0316494557.USD","ELIL","FTXH","LU0114720955.EUR","LU1983299246.USD","LU0882574139.USD","LU1861558580.USD","LU2746668974.SGD","SGXZ31699556.SGD","IXJ","LU2746668461.USD","LU2271345857.HKD","LU2237443895.HKD","LU0158827948.USD","LU0061475181.USD","WGMI","LU0354030438.USD","IE00BWXC8680.SGD","LU1093756325.SGD","LU0130103400.USD","IE0001KFT4U8.USD","LU0133085943.USD","LU2491050154.USD","LU2168564495.EUR","THNR","LU0943347566.SGD","ELIS","LU2023250330.USD","SG9999015986.USD","LU2602419157.SGD","IE00BKDWB100.SGD","LU1815336091.USD","IE00B4R5TH58.HKD","LU2265009873.SGD","LU0889565916.HKD","LU2023250504.SGD","LU0256863811.USD","LU2361044865.SGD","IE0009355771.USD","ILDR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667641178","title":"Vera Therapeutics Shares Gain on Positive Late-Stage Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2667641178","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667641178?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:19","pubTimestamp":1789471140,"startTime":"0","endTime":"0","summary":"Shares of Vera Therapeutics climbed after the company said Trutakna, a treatment which helps mitigate the progression of certain kidney diseases, met all prespecified endpoints in a late-stage trial.The stock rose 9.8%, to $37.39, in premarket trading Tuesday. Through Monday's close, shares have lost roughly 30% of their value year to date.Vera before the bell said Trutakna achieved a statistically-significant reduction in risk of composite kidney disease progression, including proteinuria, or an excess of protein in urine.Trutakna was well tolerated, with a favorable safety profile generally comparable to placebo, the biotechnology company added. The treatment was tested in adult patients with primary IgA nephropathy at risk for disease progression.IgAN is a serious, progressive, immune-mediated kidney disease, as well as a leading cause of chronic kidney disease and kidney failure worldwide, according to Vera.Chief Executive Marshall Fordyce said Vera intends to submit a supplemental","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Vera Therapeutics Shares Gain on Positive Late-Stage Trial Results","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","BK4539","BK4588","BK4139","VERA","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667439641","title":"Vera Therapeutics Reports Successful TRUTAKNA Phase 3 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2667439641","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667439641?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:17","pubTimestamp":1789471051,"startTime":"0","endTime":"0","summary":"Vera Therapeutics ( ($VERA) ) has shared an announcement. On September 15, 2026, Vera Therapeutics reported that TRUTAKNA met all prespecified endp...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vera-therapeutics-reports-successful-trutakna-phase-3-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vera-therapeutics-reports-successful-trutakna-phase-3-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4139","BK4539","BK4585","VERA","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667641500","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2667641500","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667641500?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:12","pubTimestamp":1789470776,"startTime":"0","endTime":"0","summary":"Advasa  shares were up more than 49% in Tuesday's premarket activity, rebounding from a 58% loss in the previous session.Vera Therapeutics  stock was over 14% higher after the company said its kidney disease drug met all prespecified endpoints in a phase 3 trial final efficacy analysis.Radiant Logistics  shares were up 13% after the company reported higher fiscal Q4 adjusted earnings and revenue.Editas Medicine  stock was 9% higher after a 1.5% advance in the prior day's session.Eltek  shares were up 7%, extending Monday's 10% rise.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2324357040.USD","VERA","ADBT","BK4556","EDIT","BK4131","ELTK","BK4585","RLGT","BK4023","BK4148","BK4539","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667641487","title":"Vera Therapeutics up 13% in pre-market at $38.63 after trutakna ORIGIN 3 data","url":"https://stock-news.laohu8.com/highlight/detail?id=2667641487","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667641487?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:11","pubTimestamp":1789470660,"startTime":"0","endTime":"0","summary":"07:05 EDT Vera Therapeutics (VERA) up 13% in pre-market at $38.63 after trutakna ORIGIN 3 data Published first on TheFly – the ultimate source for ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vera-therapeutics-up-13-in-pre-market-at-38-63-after-trutakna-origin-3-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vera-therapeutics-up-13-in-pre-market-at-38-63-after-trutakna-origin-3-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","BK4588","VERA","LU2324357040.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667418686","title":"Vera Therapeutics Gains After Kidney Disease Drug Meets Goals in Confirmatory Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2667418686","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667418686?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:03","pubTimestamp":1789470213,"startTime":"0","endTime":"0","summary":"BUZZ-Vera Therapeutics gains after kidney disease drug meets goals in confirmatory trial** Shares of Vera TherapeuticsVERA.Orise 11.6% to $38 premarket** Company says its drug Trutakna has met all goa","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL4N4570R9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4139","BK4588","VERA","BK4539","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667495586","title":"Vera Therapeutics’ trutakna meets all efficacy endpoints in IgAN trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2667495586","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667495586?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:41","pubTimestamp":1789468891,"startTime":"0","endTime":"0","summary":"Vera Therapeutics (VERA) announced that trutakna met all prespecified endpoints of the final efficacy analysis of the ORIGIN 3 trial in adults with...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vera-therapeutics-trutakna-meets-all-efficacy-endpoints-in-igan-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vera-therapeutics-trutakna-meets-all-efficacy-endpoints-in-igan-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VERA","LU2324357040.USD","BK4139","BK4585","BK4588","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667646227","title":"Vera Therapeutics, - Trutakna Demonstrates Favorable Safety Profile Generally Comparable to Placebo","url":"https://stock-news.laohu8.com/highlight/detail?id=2667646227","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667646227?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:30","pubTimestamp":1789468207,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nFWN4560RM:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4139","VERA","BK4585","LU2324357040.USD","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667462776","title":"Vera Therapeutics, - Plans to Submit Supplemental Bla to FDA for Full Approval in Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2667462776","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667462776?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:30","pubTimestamp":1789468207,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nFWN4560RM:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4585","LU2324357040.USD","BK4139","VERA","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667279646","title":"Vera Therapeutics Announces Trutakna™ (Atacicept-Vymj) Stabilized Egfr and Prevented Kidney Disease Progression Through Two Years in Origin 3 Final Efficacy Analysis in Iga Nephropathy","url":"https://stock-news.laohu8.com/highlight/detail?id=2667279646","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667279646?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:30","pubTimestamp":1789468207,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nFWN4560RM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4585","VERA","BK4539","BK4588","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667164627","title":"Vera Therapeutics, - Trutakna Meets All Prespecified Endpoints in Origin 3 Final Efficacy Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2667164627","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667164627?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:30","pubTimestamp":1789468207,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nFWN4560RM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4585","VERA","BK4539","BK4139","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666379001","title":"Vera Therapeutics is Maintained at Overweight by JP Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2666379001","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666379001?lang=en_us&edition=fundamental","pubTime":"2026-09-08 23:57","pubTimestamp":1788883020,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/VERA/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VERA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.veratx.com","stockEarnings":[{"period":"1week","weight":-0.0271},{"period":"1month","weight":-0.055},{"period":"3month","weight":-0.2148},{"period":"6month","weight":-0.142},{"period":"1year","weight":0.2754},{"period":"ytd","weight":-0.3416}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":0.0017},{"period":"3month","weight":0.0524},{"period":"6month","weight":0.2099},{"period":"1year","weight":0.1605},{"period":"ytd","weight":0.125}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy; and for treatment of lupus nephritis. It is also developing MAU868, a monoclonal antibody for the treatment of BK viremia infections. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":0.057587},{"month":2,"riseRate":0.4,"avgChangeRate":0.015839},{"month":3,"riseRate":0.4,"avgChangeRate":-0.047765},{"month":4,"riseRate":0,"avgChangeRate":-0.103447},{"month":5,"riseRate":0.2,"avgChangeRate":-0.049498},{"month":6,"riseRate":0.5,"avgChangeRate":0.171762},{"month":7,"riseRate":0.666667,"avgChangeRate":0.072704},{"month":8,"riseRate":0.666667,"avgChangeRate":0.026207},{"month":9,"riseRate":0.5,"avgChangeRate":0.070436},{"month":10,"riseRate":0.2,"avgChangeRate":-0.071412},{"month":11,"riseRate":0.8,"avgChangeRate":0.292871},{"month":12,"riseRate":0.6,"avgChangeRate":0.07812}],"exchange":"NASDAQ","name":"Vera Therapeutics, Inc.","nameEN":"Vera Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Vera Therapeutics, Inc.(VERA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Vera Therapeutics, Inc.(VERA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Vera Therapeutics, Inc.,VERA,Vera Therapeutics, Inc.股票,Vera Therapeutics, Inc.股票老虎,Vera Therapeutics, Inc.股票老虎国际,Vera Therapeutics, Inc.行情,Vera Therapeutics, Inc.股票行情,Vera Therapeutics, Inc.股价,Vera Therapeutics, Inc.股市,Vera Therapeutics, Inc.股票价格,Vera Therapeutics, Inc.股票交易,Vera Therapeutics, Inc.股票购买,Vera Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Vera Therapeutics, Inc.(VERA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Vera Therapeutics, Inc.(VERA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction